Rareview Capital LLC Sells 426 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Rareview Capital LLC lowered its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 4,154 shares of the exchange traded fund’s stock after selling 426 shares during the period. Rareview Capital LLC’s holdings in SPDR S&P Biotech ETF were worth $410,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of XBI. Howard Capital Management Group LLC grew its holdings in SPDR S&P Biotech ETF by 2.6% during the third quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock worth $24,514,000 after purchasing an additional 6,188 shares during the period. Atria Investments Inc boosted its holdings in shares of SPDR S&P Biotech ETF by 2.1% during the third quarter. Atria Investments Inc now owns 9,016 shares of the exchange traded fund’s stock worth $891,000 after acquiring an additional 188 shares during the period. Dearborn Partners LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 10.9% during the third quarter. Dearborn Partners LLC now owns 2,705 shares of the exchange traded fund’s stock worth $267,000 after acquiring an additional 265 shares during the period. Signature Estate & Investment Advisors LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 5.7% during the third quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after acquiring an additional 125 shares during the period. Finally, Mirae Asset Securities USA Inc. boosted its holdings in shares of SPDR S&P Biotech ETF by 50.0% during the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after acquiring an additional 300,000 shares during the period.

SPDR S&P Biotech ETF Stock Up 1.3 %

Shares of NYSEARCA:XBI opened at $87.13 on Friday. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The stock has a market cap of $5.75 billion, a PE ratio of 11.47 and a beta of 0.93. The business has a 50 day moving average of $90.06 and a 200-day moving average of $94.86.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.